• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

医疗保险计划；终末期肾病前瞻性支付系统、向急性肾损伤患者提供的肾透析服务支付以及终末期肾病质量激励计划。最终规则。

Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.

出版信息

Fed Regist. 2017 Nov 1;82(210):50738-97.

PMID:29091373
Abstract

This rule updates and makes revisions to the end-stage renal disease (ESRD) prospective payment system (PPS) for calendar year (CY) 2018. It also updates the payment rate for renal dialysis services furnished by an ESRD facility to individuals with acute kidney injury (AKI). This rule also sets forth requirements for the ESRD Quality Incentive Program (QIP), including for payment years (PYs) 2019 through 2021.

摘要

本规则对2018日历年的终末期肾病（ESRD）前瞻性支付系统（PPS）进行更新和修订。它还更新了ESRD设施为急性肾损伤（AKI）患者提供的肾透析服务的支付费率。本规则还规定了ESRD质量激励计划（QIP）的要求，包括2019年至2021年支付年度（PYs）的要求。

相似文献

1
Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.医疗保险计划；终末期肾病前瞻性支付系统、向急性肾损伤患者提供的肾透析服务支付以及终末期肾病质量激励计划。最终规则。
Fed Regist. 2017 Nov 1;82(210):50738-97.
2
Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.医疗保险计划；终末期肾病前瞻性支付系统、为急性肾损伤患者提供的肾透析服务的覆盖范围和支付、终末期肾病质量激励计划、耐用医疗设备、假肢、矫形器及用品竞争性投标计划投标保证金、违反合同行为的州许可和上诉程序、耐用医疗设备、假肢、矫形器及用品竞争性投标计划和费用表调整、耐用医疗设备的就医问题；以及终末期肾病综合护理模式。最终规则。
Fed Regist. 2016 Nov 4;81(214):77834-969.
3
Medicare program; end-stage renal disease prospective payment system, quality incentive program, and bad debt reductions for all Medicare providers. Final rule.医疗保险计划；终末期肾病前瞻性支付系统、质量激励计划以及面向所有医疗保险提供者的坏账减免。最终规则。
Fed Regist. 2012 Nov 9;77(218):67450-531.
4
Medicare Program; End-Stage Renal Disease Prospective Payment System, and Quality Incentive Program. Final Rule.医疗保险计划；终末期肾病前瞻性支付系统及质量激励计划。最终规则。
Fed Regist. 2015 Nov 6;80(215):68967-9077.
5
Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program (CBP) and Fee Schedule Amounts, and Technical Amendments To Correct Existing Regulations Related to the CBP for Certain DMEPOS. Final rule.医疗保险计划；终末期肾病前瞻性支付系统、向急性肾损伤患者提供的肾透析服务支付、终末期肾病质量激励计划、耐用医疗设备、假肢、矫形器及用品（DMEPOS）竞争性投标计划（CBP）和费用表金额，以及纠正与某些DMEPOS的CBP相关现行法规的技术修订。最终规则。
Fed Regist. 2018 Nov 14;83(220):56922-7073.
6
Medicare program; end-stage renal disease prospective payment system and quality incentive program; ambulance fee schedule; durable medical equipment; and competitive acquisition of certain durable medical equipment prosthetics, orthotics and supplies. Final rule.医疗保险计划；终末期肾病前瞻性支付系统和质量激励计划；救护车收费表；耐用医疗设备；以及某些耐用医疗设备、假肢、矫形器和用品的竞争性采购。最终规则。
Fed Regist. 2011 Nov 10;76(218):70228-316.
7
Medicare program; End-Stage Renal Disease prospective payment system, quality incentive program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies. Final rule.医疗保险计划；终末期肾病前瞻性支付系统、质量激励计划以及耐用医疗设备、假肢、矫形器和用品。最终规则。
Fed Regist. 2014 Nov 6;79(215):66119-265.
8
Medicare programs: changes to the end-stage renal disease prospective payment system transition budget-neutrality adjustment. Interim final rule with comment period.医疗保险计划：终末期肾病前瞻性支付系统过渡预算中性调整的变更。有意见征求期的暂行最终规则。
Fed Regist. 2011 Apr 6;76(66):18930-4.
9
Medicare program; end-stage renal disease prospective payment system. Final rule.医疗保险计划；终末期肾病前瞻性支付系统。最终规则。
Fed Regist. 2010 Aug 12;75(155):49029-214.
10
Medicare program; end-stage renal disease prospective payment system, quality incentive program, and durable medical equipment, prosthetics, orthotics, and supplies.医疗保险计划；终末期肾病前瞻性支付系统、质量激励计划以及耐用医疗设备、假肢、矫形器和用品。
Fed Regist. 2013 Dec 2;78(231):72155-253.

引用本文的文献

1
Divergent Trends by Patient Age in Racial Disparities in Kidney Transplant Access.肾移植可及性种族差异中患者年龄的不同趋势
Kidney Int Rep. 2025 Jun 4;10(8):2766-2777. doi: 10.1016/j.ekir.2025.05.045. eCollection 2025 Aug.
2
Acute Kidney Injury Care Following Hospitalization: Care Provision and Public Policy for Acute Kidney Injury Survivors.住院后的急性肾损伤护理：急性肾损伤幸存者的护理提供与公共政策
Adv Kidney Dis Health. 2025 Mar;32(2):205-216. doi: 10.1053/j.akdh.2024.10.002.
3
Care Continuity, Nephrologists' Dialysis Facility Preferences, and Outcomes.
护理连续性、肾病学家对透析设施的偏好及结果
JAMA Health Forum. 2025 Apr 4;6(4):e250423. doi: 10.1001/jamahealthforum.2025.0423.
4
Bundle Fix?: We Need an Act of Congress.捆绑修复？：我们需要国会立法。
J Am Soc Nephrol. 2025 May 1;36(5):981-983. doi: 10.1681/ASN.0000000664. Epub 2025 Feb 14.
5
Better Dialysis Care in the United States Requires New Payment Policy: No Patient Left Behind.美国改善透析护理需要新的支付政策：不让任何患者掉队。
J Am Soc Nephrol. 2025 May 1;36(5):973-975. doi: 10.1681/ASN.0000000663. Epub 2025 Feb 14.
6
Incorporation of Calcimimetics into End-Stage Kidney Disease Bundle: Changes in Etelcalcetide Utilization and Parathyroid Hormone Control following End of Transitional Drug Add-On Payment Adjustment Designation.拟钙剂纳入终末期肾病综合治疗方案：过渡性药物附加支付调整指定结束后依替卡肽使用及甲状旁腺激素控制情况的变化
Clin J Am Soc Nephrol. 2024 Oct 8;20(2):218-28. doi: 10.2215/CJN.0000000583.
7
Responding to the workforce crisis: consensus recommendations from the Second Workforce Summit of the American Society of Pediatric Nephrology.应对劳动力危机：美国儿科学会肾脏病学第二次劳动力峰会的共识建议。
Pediatr Nephrol. 2024 Dec;39(12):3609-3619. doi: 10.1007/s00467-024-06410-9. Epub 2024 Jul 8.
8
Pay-for-Performance Incentives for Home Dialysis Use and Kidney Transplant.家庭透析使用和肾移植的按效付费激励措施。
JAMA Health Forum. 2024 Jun 30;5(6.9):e242055. doi: 10.1001/jamahealthforum.2024.2055.
9
Social Risk and Dialysis Facility Performance in the First Year of the ESRD Treatment Choices Model.社会风险与终末期肾病治疗选择模型实施首年的透析机构表现。
JAMA. 2024 Jan 9;331(2):124-131. doi: 10.1001/jama.2023.23649.
10
Differences in Outcomes by Place of Origin among Hispanic Patients with Kidney Failure. Hispanic 患者肾衰竭的起源地差异对预后的影响。
J Am Soc Nephrol. 2023 Dec 1;34(12):2013-2023. doi: 10.1681/ASN.0000000000000239. Epub 2023 Sep 27.